Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Strom

Showing results (141-150 of 252) with videos related to

Pageof 26
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 6, 2010
Sulforaphane- and phenethyl isothiocyanate-induced inhibition of aflatoxin B1-mediated genotoxicity in human hepatocytes: role of GSTM1 genotype and CYP3A4 gene expressionKerstin Gross-Steinmeyer, Patricia L Stapleton, Julia H Tracy, et al.
Molecular Pharmacology|August 17, 2012
The orphan nuclear receptor DAX-1 functions as a potent corepressor of the constitutive androstane receptor (NR1I3)Elizabeth M Laurenzana, Tao Chen, Malavika Kannuswamy, et al.
Tissue Engineering. Part A|October 23, 2009
Maintenance of human hepatocyte function in vitro by liver-derived extracellular matrix gelsTiffany L Sellaro, Aarati Ranade, Denver M Faulk, et al.
Nature Medicine|May 10, 2000
Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligandM Jo, T H Kim, D W Seol, et al.
Injury|December 16, 2011
Fracture pattern and fixation type related to loss of reduction in bicondylar tibial plateau fracturesMichael J Weaver, Mitchel B Harris, Adam C Strom, et al.
Hepatology (Baltimore, Md.)|December 24, 1998
Morphogenetic events in mixed cultures of rat hepatocytes and nonparenchymal cells maintained in biological matrices in the presence of hepatocyte growth factor and epidermal growth factorG K Michalopoulos, W C Bowen, V F Zajac, et al.
Current Protocols in Toxicology|November 8, 2014
The history and use of human hepatocytes for the treatment of liver diseases: the first 100 patientsMarc C Hansel, Roberto Gramignoli, Kristen J Skvorak, et al.
Transplantation Proceedings|June 1, 1995
Cardiac changes during acute allograft rejection: evaluation by serial echocardiographic measurements over a 5-year follow-up periodH U Stempfle, C Strom, C Spes, et al.
ALTEX|April 13, 2010
Long term cultures of primary human hepatocytes as an alternative to drug testing in animalsAnett Ullrich, Donna B Stolz, Ewa C Ellis, et al.
Annals of the American Thoracic Society|October 9, 2014
Quality improvement initiative to reduce deep vein thrombosis associated with peripherally inserted central catheters in adults with cystic fibrosisJoel D Mermis, Jeremy C Strom, John P Greenwood, et al.
Pageof 26

Showing results (141-150 of 252) with videos related to

Sort By:
Pageof 26
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 6, 2010
Sulforaphane- and phenethyl isothiocyanate-induced inhibition of aflatoxin B1-mediated genotoxicity in human hepatocytes: role of GSTM1 genotype and CYP3A4 gene expressionKerstin Gross-Steinmeyer, Patricia L Stapleton, Julia H Tracy, et al.
Molecular Pharmacology|August 17, 2012
The orphan nuclear receptor DAX-1 functions as a potent corepressor of the constitutive androstane receptor (NR1I3)Elizabeth M Laurenzana, Tao Chen, Malavika Kannuswamy, et al.
Tissue Engineering. Part A|October 23, 2009
Maintenance of human hepatocyte function in vitro by liver-derived extracellular matrix gelsTiffany L Sellaro, Aarati Ranade, Denver M Faulk, et al.
Nature Medicine|May 10, 2000
Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligandM Jo, T H Kim, D W Seol, et al.
Injury|December 16, 2011
Fracture pattern and fixation type related to loss of reduction in bicondylar tibial plateau fracturesMichael J Weaver, Mitchel B Harris, Adam C Strom, et al.
Hepatology (Baltimore, Md.)|December 24, 1998
Morphogenetic events in mixed cultures of rat hepatocytes and nonparenchymal cells maintained in biological matrices in the presence of hepatocyte growth factor and epidermal growth factorG K Michalopoulos, W C Bowen, V F Zajac, et al.
Current Protocols in Toxicology|November 8, 2014
The history and use of human hepatocytes for the treatment of liver diseases: the first 100 patientsMarc C Hansel, Roberto Gramignoli, Kristen J Skvorak, et al.
Transplantation Proceedings|June 1, 1995
Cardiac changes during acute allograft rejection: evaluation by serial echocardiographic measurements over a 5-year follow-up periodH U Stempfle, C Strom, C Spes, et al.
ALTEX|April 13, 2010
Long term cultures of primary human hepatocytes as an alternative to drug testing in animalsAnett Ullrich, Donna B Stolz, Ewa C Ellis, et al.
Annals of the American Thoracic Society|October 9, 2014
Quality improvement initiative to reduce deep vein thrombosis associated with peripherally inserted central catheters in adults with cystic fibrosisJoel D Mermis, Jeremy C Strom, John P Greenwood, et al.
Pageof 26